CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberson, K. M.
Right arrow Articles by Robertson, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberson, K. M.
Right arrow Articles by Robertson, C. N.

Cell Growth & Differentiation, Vol 8, Issue 1 101-111, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells

KM Roberson, SN Penland, GM Padilla, RS Selvan, CS Kim, RL Fine and CN Robertson
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

N-(4-Hydroxyphenyl)retinamide (4-HPR, Fenretinide) is a retinoid derivative with antineoplastic activity in various tumor types including prostate carcinoma. The mechanism of action of 4-HPR toxicity is unknown. 4-HPR induces apoptosis in leukemia- and lymphoma-derived cells, neuroblastoma, and small cell lung cancers. The present study was designed to investigate: (a) the mechanism of 4-HPR cytotoxicity in prostate cancer cells; and (b) correlate increased expression of transforming growth factor beta 1 (TGF beta 1) with induction of apoptosis. 4-HPR exposure to PC-3 cells in vitro was associated with apoptosis as evidenced by increased incidence of hypodiploid nuclei in propidium iodide fluorescence histograms and DNA fragmentation. An increase in the percentage of nuclei in the G1 phase of the cell cycle preceded induction of apoptosis. TGF beta 1-increased expression was noted in mRNA levels and in secretion of active TGF beta 1 into culture media. TGF beta 1 and TGF-beta receptor type II detected immunohistochemically were increased in 4-HPR-treated PC-3 cells. Furthermore, 4-HPR-induced cytotoxicity in PC-3 cells was abrogated by the addition of anti-TGF beta 1 antibody. In BT-20 cells, a 4-HPR-resistant breast carcinoma cell line, apoptosis was not observed after exposure to 4-HPR nor was TGF beta 1 expression enhanced in stained cells or in conditioned media. It is concluded that 4-HPR induces the expression of TGF beta 1 in association with the induction of apoptosis.


This article has been cited by other articles:


Home page
DevelopmentHome page
G. P. Lobo, A. Isken, S. Hoff, D. Babino, and J. von Lintig
BCDO2 acts as a carotenoid scavenger and gatekeeper for the mitochondrial apoptotic pathway
Development, August 15, 2012; 139(16): 2966 - 2977.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. C. Rodriguez, B.J. Rimel, W. Watkin, J. M. Turbov, C. Barry, H. Du, G. L. Maxwell, and J.M. Cline
Progestin Treatment Induces Apoptosis and Modulates Transforming Growth Factor-{beta} in the Uterine Endometrium
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 578 - 584.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Lu, J. Lee, M. Revelo, X. Wang, S. Lu, and Z. Dong
Smad3 Is Overexpressed in Advanced Human Prostate Cancer and Necessary for Progressive Growth of Prostate Cancer Cells in Nude Mice
Clin. Cancer Res., October 1, 2007; 13(19): 5692 - 5702.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Zhang, J. Lee, S. Lu, C. A. Pettaway, and Z. Dong
Blockade of Transforming Growth Factor-{beta} Signaling Suppresses Progression of Androgen-Independent Human Prostate Cancer in Nude Mice
Clin. Cancer Res., June 15, 2005; 11(12): 4512 - 4520.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin Lab SciHome page
R. E. Brown, M. Lun, J. W. Prichard, T. M. Blasick, and P. L. Zhang
Morphoproteomic and Pharmacoproteomic Correlates in Hormone-Receptor-Negative Breast Carcinoma Cell Lines
Ann. Clin. Lab. Sci., July 1, 2004; 34(3): 251 - 262.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
S. W. Tobin, M. K. Brown, K. Douville, D. C. Payne, A. Eastman, and B. A. Arrick
Inhibition of Transforming Growth Factor {beta} Signaling in MCF-7 Cells Results in Resistance to Tumor Necrosis Factor {{alpha}}: A Role for Bcl-2
Cell Growth Differ., February 1, 2001; 12(2): 109 - 117.
[Abstract] [Full Text]


Home page
JCOHome page
C. Thaller, M. Shalev, A. Frolov, G. Eichele, T. C. Thompson, R. H. Williams, O. Dillioglugil, and D. Kadmon
Fenretinide Therapy in Prostate Cancer: Effects on Tissue and Serum Retinoid Concentration
J. Clin. Oncol., November 15, 2000; 18(22): 3804 - 3808.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
S. Larisch-Bloch, D. Danielpour, N. S. Roche, R. Lotan, A. Y. Hsing, H. Kerner, T. Hajouj, R. J. Lechleider, and A. B. Roberts
Selective Loss of the Transforming Growth Factor-{beta} Apoptotic Signaling Pathway in Mutant NRP-154 Rat Prostatic Epithelial Cells
Cell Growth Differ., January 1, 2000; 11(1): 1 - 10.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
Y.-R. Chen, G. Zhou, and T.-H. Tan
c-Jun N-Terminal Kinase Mediates Apoptotic Signaling Induced byN-(4-Hydroxyphenyl)retinamide
Mol. Pharmacol., December 1, 1999; 56(6): 1271 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. C. Bergan, E. Reed, C. E. Myers, D. Headlee, O. Brawley, H.-K. Cho, W. D. Figg, A. Tompkins, W. M. Linehan, D. Kohler, et al.
A Phase II Study of High-Dose Tamoxifen in Patients with Hormone-refractory Prostate Cancer
Clin. Cancer Res., September 1, 1999; 5(9): 2366 - 2373.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. K. Puduvalli, Y. Saito, R. Xu, G. P. Kouraklis, V. A. Levin, and A. P. Kyritsis
Fenretinide Activates Caspases and Induces Apoptosis in Gliomas
Clin. Cancer Res., August 1, 1999; 5(8): 2230 - 2235.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.-Y. Sun, P. Yue, and R. Lotan
Induction of Apoptosis by N-(4-Hydroxyphenyl)retinamide and Its Association with Reactive Oxygen Species, Nuclear Retinoic Acid Receptors, and Apoptosis-Related Genes in Human Prostate Carcinoma Cells
Mol. Pharmacol., March 1, 1999; 55(3): 403 - 410.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. L. Clifford, D. G. Menter, M. Wang, R. Lotan, and S. M. Lippman
Retinoid Receptor-dependent and -independent Effects of N-(4-Hydroxyphenyl)retinamide in F9 Embryonal Carcinoma Cells
Cancer Res., January 1, 1999; 59(1): 14 - 18.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.